Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study.
Joly, F
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study. [electronic resource] - Gynecologic oncology Dec 2009 - 382-8 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1095-6859
10.1016/j.ygyno.2009.08.024 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Deoxycytidine--administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Middle Aged
Ovarian Neoplasms--drug therapy
Quality of Life
Topotecan--administration & dosage
Treatment Outcome
Gemcitabine
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study. [electronic resource] - Gynecologic oncology Dec 2009 - 382-8 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1095-6859
10.1016/j.ygyno.2009.08.024 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Deoxycytidine--administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Middle Aged
Ovarian Neoplasms--drug therapy
Quality of Life
Topotecan--administration & dosage
Treatment Outcome
Gemcitabine